“This highlights a need for physicians to better integrate patient preferences into their treatment recommendations," says Jonathan Bergman, MD, MPH. https://lnkd.in/eanTfrHT
About us
Urology Times takes the lead in providing news analysis of key advances in surgical and non-surgical techniques, treatments, and practice management. Urology Times has been the #1 read publication for more than 20 years, reaching the full universe of physician-specialists treating urologic disorders. We keep urologists up to date so they can quickly provide better patient care while running a more efficient practice.
- Website
-
http://www.UrologyTimes.com
External link for Urology Times
- Industry
- Book and Periodical Publishing
- Company size
- 51-200 employees
- Type
- Public Company
- Specialties
- Urology
Employees at Urology Times
Updates
-
Dr. Juan Fulla MD, MSc discusses an AI-based chat system that can assist in the follow-up of patients with urologic conditions. https://lnkd.in/erDeVTUN
Dr. Fulla highlights an AI tool for patient follow-up for urologic conditions
urologytimes.com
-
The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of enfortumab vedotin plus pembrolizumab for the first-line treatment of patients with unresectable or metastatic urothelial carcinoma. https://lnkd.in/e_rSvK2W
EV plus pembrolizumab nears EU approval for urothelial carcinoma
urologytimes.com
-
Dr. Kyrollis Attalla, MD describes the role of fusion-based biopsies in active surveillance for patients with prostate cancer. https://lnkd.in/gjMtGTaU
Fusion-Based Biopsies in Active Surveillance
urologytimes.com
-
A national payment rate and a category III CPT code have been established for Unfold AI in prostate cancer. https://lnkd.in/gzD8jPsC
Payment rate, CPT code established for Unfold AI in prostate cancer
urologytimes.com
-
"And really with this project, we've shown that inpatient post radical cystectomy is an opportune time to meet our patients during a time where they can't smoke and provide the cessation they need," says Dr. Marc Bjurlin. https://lnkd.in/gu7JmpFY
Dr. Bjurlin on “super easy” way to implement smoking cessation in patients with bladder cancer
urologytimes.com
-
Dr. Kelly Stratton discusses a phase 1B trial evaluating relugolix and enzalutamide in patients with high-risk, locally advanced prostate cancer. https://lnkd.in/eUFWbsUr
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
urologytimes.com
-
In case you missed our live X Spaces event with Dr. Ashley Winter MD on the use of vaginal estrogen, the discussion is now available as a podcast on our site! #urology Listen to Dr. Winter's insights here: https://lnkd.in/eZHiAhru
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
urologytimes.com
-
The FDA has accepted a new drug application seeking approval of TLX007-CDx, a cold kit for the preparation of PSMA-PET imaging for prostate cancer. https://lnkd.in/eECrGAbF
TLX007-CDx under FDA review for approval in prostate cancer
urologytimes.com
-
All patients have completed the 6-month primary end point visit in the SANS-UUI trial, which is evaluating the safety and efficacy of the Neuspera Implantable SNM System in patients with UUI. https://lnkd.in/ewaeNuW7
Trial progresses of SNM device for OAB-related incontinence
urologytimes.com